Amgen Inc. Financing Cash Flow
Amgen Inc. (AMGN) reported Financing Cash Flow of -$46.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- Amgen Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$1.48B.
- Amgen Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.44B.
- Amgen Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.23B.
- Amgen Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$2.85B.
- Amgen Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$10.86B.
- Amgen Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$9.41B, a 144.73% decline from fiscal 2023.
- Amgen Inc. net cash provided by (used in) financing activities for fiscal 2023 was $21.05B.
- Amgen Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$4.04B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.48B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$46.00M 10-Q · filed 2026-08-05 | -$1.27B derived: sum of 3 quarters · filed 2026-08-05 | -$4.13B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.44B 10-Q · filed 2026-05-01 | $210.00M derived: sum of 2 quarters · filed 2026-05-01 | -$2.64B derived: sum of 3 quarters · filed 2026-05-01 | -$5.32B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$4.08B derived: sum of 2 quarters · filed 2026-02-13 | -$6.75B derived: sum of 3 quarters · filed 2026-08-05 | -$10.86B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | -$2.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.53B derived: sum of 2 quarters · filed 2026-08-05 | -$9.63B 10-Q · filed 2025-11-05 | -$11.04B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$2.67B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$6.78B 10-Q · filed 2026-08-05 | -$8.19B derived: sum of 3 quarters · filed 2026-08-05 | -$11.84B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$4.11B 10-Q · filed 2026-05-01 | -$5.51B derived: sum of 2 quarters · filed 2026-05-01 | -$9.16B derived: sum of 3 quarters · filed 2026-05-01 | -$11.81B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | -$1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$5.06B derived: sum of 2 quarters · filed 2026-02-13 | -$7.71B derived: sum of 3 quarters · filed 2026-02-13 | -$9.41B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | -$3.65B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$6.30B derived: sum of 2 quarters · filed 2025-11-05 | -$8.01B 10-Q · filed 2025-11-05 | -$5.25B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$2.65B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.36B 10-Q · filed 2025-08-06 | -$1.60B derived: sum of 3 quarters · filed 2026-02-13 | -$3.61B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | -$1.71B 10-Q · filed 2025-05-02 | $1.05B derived: sum of 2 quarters · filed 2026-02-13 | -$959.00M derived: sum of 3 quarters · filed 2026-02-13 | -$2.17B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $749.00M derived: sum of 2 quarters · filed 2026-02-13 | -$461.00M derived: sum of 3 quarters · filed 2026-02-13 | $21.05B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | -$2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$3.21B derived: sum of 2 quarters · filed 2024-10-31 | $18.29B 10-Q · filed 2024-10-31 | $17.25B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | -$1.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.30B 10-Q · filed 2024-08-07 | $19.25B derived: sum of 3 quarters · filed 2025-02-14 | $20.84B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $21.51B 10-Q · filed 2024-05-03 | $20.46B derived: sum of 2 quarters · filed 2025-02-14 | $22.05B derived: sum of 3 quarters · filed 2025-02-14 | $20.99B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | -$1.05B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $539.00M derived: sum of 2 quarters · filed 2025-02-14 | -$523.00M derived: sum of 3 quarters · filed 2025-02-14 | -$4.04B 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $1.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $526.00M derived: sum of 2 quarters · filed 2023-10-31 | -$2.99B 10-Q · filed 2023-10-31 | -$9.55B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$4.58B 10-Q · filed 2023-08-04 | -$11.13B derived: sum of 3 quarters · filed 2024-02-14 | -$8.29B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$3.51B 10-Q · filed 2023-04-28 | -$10.07B derived: sum of 2 quarters · filed 2024-02-14 | -$7.22B derived: sum of 3 quarters · filed 2024-02-14 | -$9.85B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$6.56B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$3.71B derived: sum of 2 quarters · filed 2024-02-14 | -$6.33B derived: sum of 3 quarters · filed 2024-02-14 | -$8.27B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $2.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $226.00M derived: sum of 2 quarters · filed 2022-11-04 | -$1.71B 10-Q · filed 2022-11-04 | -$5.30B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | -$2.62B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$4.56B 10-Q · filed 2022-08-05 | -$8.15B derived: sum of 3 quarters · filed 2023-02-09 | -$9.95B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | -$1.94B 10-Q · filed 2022-04-28 | -$5.53B derived: sum of 2 quarters · filed 2023-02-09 | -$7.33B derived: sum of 3 quarters · filed 2023-02-09 | -$6.55B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | -$3.59B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$5.39B derived: sum of 2 quarters · filed 2023-02-09 | -$4.61B derived: sum of 3 quarters · filed 2023-02-09 | -$4.87B 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | -$1.80B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$1.02B derived: sum of 2 quarters · filed 2021-11-03 | -$1.28B 10-Q · filed 2021-11-03 | -$3.21B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $775.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $521.00M 10-Q · filed 2021-08-04 | -$1.41B derived: sum of 3 quarters · filed 2022-02-16 | -$4.27B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$254.00M 10-Q · filed 2021-04-28 | -$2.18B derived: sum of 2 quarters · filed 2022-02-16 | -$5.04B derived: sum of 3 quarters · filed 2022-02-16 | -$11.03B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$4.79B derived: sum of 2 quarters · filed 2022-02-16 | -$10.78B derived: sum of 3 quarters · filed 2022-02-16 | -$15.77B 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | -$2.86B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$8.85B derived: sum of 2 quarters · filed 2020-10-29 | -$13.84B 10-Q · filed 2020-10-29 | -$17.41B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | -$5.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$10.98B 10-Q · filed 2020-07-29 | -$14.55B derived: sum of 3 quarters · filed 2021-02-09 | -$17.13B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | -$4.99B 10-Q · filed 2020-05-01 | -$8.55B derived: sum of 2 quarters · filed 2021-02-09 | -$11.13B derived: sum of 3 quarters · filed 2021-02-09 | -$15.79B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | -$3.57B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$6.15B derived: sum of 2 quarters · filed 2021-02-09 | -$10.80B derived: sum of 3 quarters · filed 2021-02-09 | -$22.49B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | -$2.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$7.23B derived: sum of 2 quarters · filed 2019-10-30 | -$18.92B 10-Q · filed 2019-10-30 | -$21.06B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-06-30 | -$4.65B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$16.34B 10-Q · filed 2019-07-31 | -$18.48B derived: sum of 3 quarters · filed 2020-02-12 | -$19.58B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-03-31 | -$11.69B 10-Q · filed 2019-05-01 | -$13.83B derived: sum of 2 quarters · filed 2020-02-12 | -$14.93B derived: sum of 3 quarters · filed 2020-02-12 | -$16.18B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2017-12-31 | -$2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$3.24B derived: sum of 2 quarters · filed 2020-02-12 | -$4.48B derived: sum of 3 quarters · filed 2020-02-12 | -$6.59B 10-K · filed 2020-02-12 | ||||
| 2017-09-30 | -$1.11B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$2.35B derived: sum of 2 quarters · filed 2018-10-31 | -$4.46B 10-Q · filed 2018-10-31 | -$6.58B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | -$1.24B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$3.35B 10-Q · filed 2018-07-27 | -$5.47B derived: sum of 3 quarters · filed 2019-02-13 | -$4.89B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | -$2.11B 10-Q · filed 2018-04-25 | -$4.23B derived: sum of 2 quarters · filed 2019-02-13 | -$3.65B derived: sum of 3 quarters · filed 2019-02-13 | -$5.94B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | -$2.12B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$1.54B derived: sum of 2 quarters · filed 2019-02-13 | -$3.83B derived: sum of 3 quarters · filed 2019-02-13 | -$2.60B 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $582.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$1.70B derived: sum of 2 quarters · filed 2017-10-26 | -$477.00M 10-Q · filed 2017-10-26 | -$1.40B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | -$2.29B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$1.06B 10-Q · filed 2017-07-26 | -$1.98B derived: sum of 3 quarters · filed 2018-02-13 | -$3.44B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | $1.23B 10-Q · filed 2017-04-27 | $305.00M derived: sum of 2 quarters · filed 2018-02-13 | -$1.15B derived: sum of 3 quarters · filed 2018-02-13 | -$1.15B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-31 | -$922.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$2.38B derived: sum of 2 quarters · filed 2018-02-13 | -$2.37B derived: sum of 3 quarters · filed 2018-02-13 | -$3.77B 10-K · filed 2018-02-13 | -$3.12B 10-K · filed 2016-02-16 | |||
| 2015-09-30 | -$1.46B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$1.45B derived: sum of 2 quarters · filed 2016-10-28 | -$2.85B 10-Q · filed 2016-10-28 | -$2.21B 10-Q · filed 2015-11-02 | -$6.01B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$1.39B 10-Q · filed 2016-07-29 | -$768.00M 10-Q · filed 2015-08-05 | -$4.55B derived: sum of 3 quarters · filed 2017-02-14 | -$5.07B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-31 | -$1.40B 10-Q · filed 2016-05-02 | -$1.24B 10-Q · filed 2015-04-27 | -$4.56B derived: sum of 2 quarters · filed 2017-02-14 | -$5.07B derived: sum of 3 quarters · filed 2017-02-14 | -$4.18B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-31 | -$3.16B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$3.67B derived: sum of 2 quarters · filed 2017-02-14 | -$2.78B derived: sum of 3 quarters · filed 2017-02-14 | -$3.27B 10-K · filed 2017-02-14 | -$2.88B 10-K · filed 2015-02-19 | |||
| 2014-09-30 | -$513.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $383.00M derived: sum of 2 quarters · filed 2015-11-02 | -$112.00M 10-Q · filed 2015-11-02 | $3.46B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-06-30 | $896.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $401.00M 10-Q · filed 2015-08-05 | $3.97B derived: sum of 3 quarters · filed 2016-10-31 | $6.76B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-03-31 | -$495.00M 10-Q · filed 2015-04-27 | $3.08B derived: sum of 2 quarters · filed 2016-10-31 | $5.86B derived: sum of 3 quarters · filed 2016-10-31 | $5.58B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2013-12-31 | $3.57B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $6.36B derived: sum of 2 quarters · filed 2016-10-31 | $6.08B derived: sum of 3 quarters · filed 2016-10-31 | $2.49B 8-K · filed 2016-10-31 | $2.73B 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $2.79B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $2.50B derived: sum of 2 quarters · filed 2014-10-29 | -$1.08B 10-Q · filed 2014-10-29 | -$2.43B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | -$283.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$3.87B 10-Q · filed 2014-08-05 | -$5.21B derived: sum of 3 quarters · filed 2015-02-19 | -$3.79B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | -$3.58B 10-Q · filed 2014-04-30 | -$4.93B derived: sum of 2 quarters · filed 2015-02-19 | -$3.51B derived: sum of 3 quarters · filed 2015-02-19 | -$1.80B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | -$1.35B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $77.00M derived: sum of 2 quarters · filed 2015-02-19 | $1.78B derived: sum of 3 quarters · filed 2015-02-19 | $419.00M 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $1.42B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $3.13B derived: sum of 2 quarters · filed 2013-10-29 | $1.77B 10-Q · filed 2013-10-29 | $3.46B derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-06-30 | $1.71B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $342.00M 10-Q · filed 2013-08-06 | $2.03B derived: sum of 3 quarters · filed 2014-02-24 | -$186.00M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-03-31 | -$1.36B 10-Q · filed 2013-05-03 | $326.00M derived: sum of 2 quarters · filed 2014-02-24 | -$1.89B derived: sum of 3 quarters · filed 2014-02-24 | $457.00M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2011-12-31 | $1.69B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$528.00M derived: sum of 2 quarters · filed 2014-02-24 | $1.82B derived: sum of 3 quarters · filed 2014-02-24 | -$674.00M 10-K · filed 2014-02-24 | ||||
| 2011-09-30 | -$2.22B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $131.00M derived: sum of 2 quarters · filed 2012-11-06 | -$2.37B 10-Q · filed 2012-11-06 | -$3.55B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $2.35B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$146.00M 10-Q · filed 2012-08-08 | -$1.33B derived: sum of 3 quarters · filed 2013-02-27 | -$119.00M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | -$2.50B 10-Q · filed 2012-05-08 | -$3.68B derived: sum of 2 quarters · filed 2013-02-27 | -$2.47B derived: sum of 3 quarters · filed 2013-02-27 | -$3.15B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | -$1.18B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $27.00M derived: sum of 2 quarters · filed 2013-02-27 | -$656.00M derived: sum of 3 quarters · filed 2013-02-27 | -$1.23B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $1.21B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $525.00M derived: sum of 2 quarters · filed 2011-11-04 | -$51.00M 10-Q · filed 2011-11-04 | -$2.23B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | -$683.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$1.26B 10-Q · filed 2011-08-08 | -$3.44B derived: sum of 3 quarters · filed 2012-02-29 | -$3.38B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | -$576.00M 10-Q · filed 2011-05-10 | -$2.75B derived: sum of 2 quarters · filed 2012-02-29 | -$2.70B derived: sum of 3 quarters · filed 2012-02-29 | -$2.60B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | -$2.18B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$2.12B derived: sum of 2 quarters · filed 2012-02-29 | -$2.03B derived: sum of 3 quarters · filed 2012-02-29 | -$2.02B 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $148.00M derived: sum of 2 quarters · filed 2010-11-08 | $153.00M 10-Q · filed 2010-11-08 | -$1.45B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-30 | $93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $98.00M 10-Q · filed 2010-08-09 | -$1.50B derived: sum of 3 quarters · filed 2011-02-25 | -$1.44B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-31 | $5.00M 10-Q · filed 2010-05-07 | -$1.59B derived: sum of 2 quarters · filed 2011-02-25 | -$1.53B derived: sum of 3 quarters · filed 2011-02-25 | |||||
| 2008-12-31 | -$1.60B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$1.53B derived: sum of 2 quarters · filed 2011-02-25 | -$3.07B 10-K · filed 2011-02-25 | |||||
| 2008-09-30 | $65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | -$1.48B 10-Q · filed 2009-11-06 | ||||||
| 2008-06-30 | -$1.54B 10-Q · filed 2009-08-10 | |||||||
| 2007-12-31 | -$2.67B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |